ImmuneRegen BioSciences is engaged in the research and development of the drug candidate, Homspera® for use as an immunomodulatory agent and stimulator of human adult stem cells. The company is focused on developing therapeutics aimed at specific disease targets including influenza, cancers (solid and blood), pulmonary fibrosis and neutropenia. Other areas of research for potential applications include stimulation of stem cells and wound healing. The company is also pursuing Homspera for use as a possible countermeasure for homeland security threats including radiation exposure, and chemical and biological agents.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Scottsdale, Az
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- immuneregen.com
- HQ
- Scottsdale, AZ
- Competitors
Immuneregen Biosciences Questions
Immuneregen Biosciences's website is immuneregen.com
Immuneregen Biosciences's LinkedIn profile is https://www.linkedin.com/company/immuneregen-biosciences
Immuneregen Biosciences has
2 employees.
View email and phone details for 2
employees at Immuneregen Biosciences.
Immuneregen Biosciences's industry is
Pharmaceutical Manufacturing
Immuneregen Biosciences's categories are Pharmaceutical Manufacturing
Immuneregen Biosciences's founding year is 2001
